IHS Chemical Week

Regions :: Western Europe :: Germany

Merck KGaA appoints Simon Sturge as new head of biosimilars unit

3:19 AM MST | February 20, 2014 | Deepti Ramesh

Merck KGaA says that Simon Sturge will join the company from Boehringer Ingelheim (Ingelheim, Germany) effective 1 March 2014, to head the biosimilars unit. The Simon Sturge. biosimilars unit is part of Merck’s pharmaceutical businesses alongside with Merck Serono (Darmstadt, Germany), the consumer health division and the Allergopharma unit. Sturge, in his new role, will report to Stefan Oschmann, member of Merck’s executive board and responsible for the company’s pharmaceutical businesses. Sturge succeeds Thierry Hulot, who created the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa